1. Home
  2. TGTX vs DDS Comparison

TGTX vs DDS Comparison

Compare TGTX & DDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$49.93

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$638.24

Market Cap

8.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGTX
DDS
Founded
1993
1938
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.2B
IPO Year
2008
2012

Fundamental Metrics

Financial Performance
Metric
TGTX
DDS
Price
$49.93
$638.24
Analyst Decision
Strong Buy
Sell
Analyst Count
5
3
Target Price
$49.80
$519.67
AVG Volume (30 Days)
2.3M
109.2K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
5.55%
EPS Growth
1746.67
N/A
EPS
0.17
16.04
Revenue
$2,785,000.00
$6,563,336,000.00
Revenue This Year
$49.08
$0.99
Revenue Next Year
$26.69
$1.09
P/E Ratio
$293.53
$40.28
Revenue Growth
N/A
N/A
52 Week Low
$26.76
$487.74
52 Week High
$59.30
$741.98

Technical Indicators

Market Signals
Indicator
TGTX
DDS
Relative Strength Index (RSI) 44.73 70.42
Support Level $45.37 $568.04
Resistance Level $58.08 $677.99
Average True Range (ATR) 2.12 22.37
MACD -0.51 5.92
Stochastic Oscillator 38.04 93.84

Price Performance

Historical Comparison
TGTX
DDS

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. It operates Dillard's stores, clearance centers, and an Internet store at dillards.com, offering a wide selection of merchandise, including fashion apparel for women, men, and children, accessories, cosmetics, home furnishings, and other consumer goods. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company also operates a general contracting construction company, which is involved in constructing and remodelling stores for Dillard's. It operates in two business segments: Retail Operations, which generates the maximum revenue, and Construction.

Share on Social Networks: